<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Schema Ictus Ischemico - Guida Completa</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Arial', sans-serif;
            line-height: 1.3;
            background: white;
            color: #000;
            padding: 4px;
        }
        
        .container {
            max-width: 800px;
            margin: 0 auto;
            background: white;
        }
        
        .main-header {
            background: #d32f2f;
            color: white;
            text-align: center;
            font-weight: bold;
            font-size: clamp(14px, 4vw, 20px);
            padding: 8px;
            margin-bottom: 8px;
            border-radius: 6px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.2);
        }
        
        .quick-note {
            text-align: center;
            margin-bottom: 8px;
            font-weight: bold;
            color: #d32f2f;
            font-size: clamp(10px, 2.5vw, 14px);
            background: #ffebee;
            padding: 4px;
            border-radius: 4px;
            border-left: 4px solid #d32f2f;
        }
        
        .section {
            margin-bottom: 8px;
            border: 1px solid #333;
            border-radius: 6px;
            overflow: hidden;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        
        .section-title {
            color: white;
            font-weight: bold;
            font-size: clamp(11px, 3vw, 15px);
            padding: 6px;
            text-align: center;
            background: #1976d2;
        }
        
        .section-title.urgent {
            background: #ff5722;
        }
        
        .section-title.success {
            background: #388e3c;
        }
        
        .section-title.warning {
            background: #f57c00;
        }
        
        .section-content {
            padding: 8px;
        }
        
        .time-critical {
            color: #d32f2f;
            font-weight: bold;
        }
        
        .flowchart {
            background: #f3e5f5;
            border-left: 4px solid #9c27b0;
            padding: 8px;
            margin: 6px 0;
            font-size: clamp(9px, 2.5vw, 12px);
            border-radius: 4px;
        }
        
        .criteria-box {
            background: #e8f5e8;
            border: 2px solid #4caf50;
            padding: 8px;
            margin: 6px 0;
            font-size: clamp(9px, 2.5vw, 12px);
            border-radius: 4px;
        }
        
        .rule-of-six {
            background: #e1f5fe;
            border: 2px solid #0288d1;
            padding: 8px;
            margin: 6px 0;
            font-weight: bold;
            font-size: clamp(9px, 2.5vw, 12px);
            border-radius: 4px;
        }
        
        .dosage {
            background: #fff3e0;
            padding: 8px;
            font-weight: bold;
            border-left: 4px solid #ff9800;
            margin: 6px 0;
            font-size: clamp(9px, 2.5vw, 12px);
            border-radius: 4px;
        }
        
        ul {
            list-style: none;
            padding-left: 16px;
            font-size: clamp(8px, 2.5vw, 11px);
        }
        
        li {
            margin-bottom: 2px;
            position: relative;
        }
        
        li::before {
            content: "‚Ä¢ ";
            color: #1976d2;
            font-weight: bold;
            position: absolute;
            left: -12px;
        }
        
        .contraindication::before {
            content: "‚úó ";
            color: #d32f2f;
        }
        
        .indication::before {
            content: "‚úì ";
            color: #388e3c;
        }
        
        .text-content {
            font-size: clamp(9px, 2.5vw, 12px);
            margin-bottom: 6px;
        }
        
        .bold {
            font-weight: bold;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            font-size: clamp(8px, 2.2vw, 11px);
            margin: 6px 0;
            background: white;
            border-radius: 4px;
            overflow: hidden;
            box-shadow: 0 1px 3px rgba(0,0,0,0.1);
        }
        
        td, th {
            border: 1px solid #ddd;
            padding: 6px;
            text-align: left;
        }
        
        th {
            background: #e3f2fd;
            font-weight: bold;
            color: #1976d2;
        }
        
        .two-column {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 8px;
            font-size: clamp(8px, 2.5vw, 11px);
        }
        
        .highlight-note {
            background: #fff9c4;
            border: 2px solid #fbc02d;
            padding: 6px;
            margin: 6px 0;
            font-weight: bold;
            font-size: clamp(9px, 2.5vw, 12px);
            border-radius: 4px;
        }
        
        .emergency-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 8px;
            font-size: clamp(8px, 2.5vw, 11px);
        }
        
        .emergency-item {
            background: #ffebee;
            border-left: 4px solid #f44336;
            padding: 6px;
            border-radius: 4px;
            margin-bottom: 6px;
        }
        
        .tabs {
            display: flex;
            background: #f5f5f5;
            border-radius: 6px;
            margin-bottom: 8px;
            overflow: hidden;
        }
        
        .tab {
            flex: 1;
            padding: 8px;
            text-align: center;
            font-weight: bold;
            font-size: clamp(10px, 3vw, 14px);
            cursor: pointer;
            background: #e0e0e0;
            border: none;
            transition: background 0.3s;
        }
        
        .tab.active {
            background: #1976d2;
            color: white;
        }
        
        .tab-content {
            display: none;
        }
        
        .tab-content.active {
            display: block;
        }
        
        /* Responsive improvements */
        @media (max-width: 600px) {
            .two-column {
                grid-template-columns: 1fr;
            }
            
            .emergency-grid {
                grid-template-columns: 1fr;
            }
            
            table {
                font-size: 10px;
            }
            
            td, th {
                padding: 4px;
            }
        }
        
        @media (max-width: 400px) {
            body {
                padding: 2px;
            }
            
            .section-content {
                padding: 6px;
            }
            
            .flowchart, .criteria-box, .rule-of-six, .dosage {
                padding: 6px;
            }
        }
        
        /* Print styles */
        @media print {
            body {
                font-size: 8px;
                line-height: 1.2;
            }
            
            .container {
                max-width: none;
            }
            
            .section {
                break-inside: avoid;
                margin-bottom: 4px;
            }
            
            .tabs {
                display: none;
            }
            
            .tab-content {
                display: block !important;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="main-header">
            üß† ICTUS ISCHEMICO - GUIDA COMPLETA
        </div>
        <a href="flowchart/ictus_acuto.md">Visualizza flow-chart</a>
        <div class="quick-note">
            üìû mRS, ora di esordio, clinica, terapia domiciliare
        </div>
        
        <div class="tabs">
            <button class="tab active" onclick="showTab(0)">üìã Valutazione</button>
            <button class="tab" onclick="showTab(1)">üíä Farmaci</button>
        </div>
        
        <!-- TAB 1: VALUTAZIONE -->
        <div class="tab-content active" id="tab0">
            <!-- VALUTAZIONE INIZIALE -->
            <div class="section">
                <div class="section-title urgent">üö® VALUTAZIONE IMMEDIATA</div>
                <div class="section-content">
                    <div class="flowchart">
                        <div class="bold">1. Clinica:</div>Ora esordio,<a href="https://www.ninds.nih.gov/sites/default/files/documents/NIH_Stroke_Scale_508C_0.pdf" target="_blank" class="download-btn">
                        üìÑNIHSS<br>
                        </a>
                        <div class="bold">2. Vitali:</div>PA, glicemia, temperatura<br>
                        <div class="bold">3. Urgente:</div>ECG, farmaci, prelievi<br>
                        <div class="bold">4. Imaging:</div>TC ¬± Angio/Perfusione
                    
                    </div>
                </div>
            </div>

            <!-- IMAGING E DECISIONI -->
            <div class="section">
                <div class="section-title">üîç FLUSSO DECISIONALE</div>
                <div class="section-content">
                    <div class="flowchart">
                        <div class="bold">TC con EMORRAGIA ‚Üí NO trombolisi</div><br>
                        <div class="bold">TC senza emorragia ‚Üí Analizza vaso:</div><br>
                        ‚Ä¢ <span class="bold">LVO:</span> ICA-T, M1, Basilare<br>
                        ‚Ä¢ <span class="bold">MeVO:</span> M2/M3, A2/A3, P2/P3<br>
                        ‚Ä¢ <span class="bold">Piccoli vasi:</span> terapia medica<br>
                        <div class="bold">BASILARE (BAO):</div> IVT+EVT entro 24h
                    </div>
                </div>
            </div>

            <!-- TROMBOLISI -->
            <div class="section">
                <div class="section-title success">üíâ TROMBOLISI EV</div>
                <div class="section-content">
                    <div class="criteria-box">
                        <div class="bold">CANDIDATI se:</div><br>
                        ‚Ä¢ Tempo &lt;4,5h o mismatch imaging<br>
                        ‚Ä¢ PA &lt;185/110, glicemia 50-400<br>
                        ‚Ä¢ INR &lt;1,7, PLT &gt;100k, no DOAC recenti<br>
                        ‚Ä¢ Assenza controindicazioni
                    </div>
                    <div class="text-content">
                        <span class="bold">WAKE-UP:</span> DWI+/FLAIR-<br>
                        <span class="bold">EXTEND:</span> core &lt;70ml, penombra &gt;10ml, ratio &gt;1,2
                    </div>
                </div>
            </div>

            <!-- TROMBECTOMIA -->
            <div class="section">
                <div class="section-title success">üîß TROMBECTOMIA</div>
                <div class="section-content">
                    <div class="rule-of-six">
                        <div class="bold">INDICAZIONI:</div><br>
                        ‚Ä¢ Tempo &lt;6h<br>
                        ‚Ä¢ NIHSS ‚â•6<br>
                        ‚Ä¢ mRS ‚â§2<br>
                        <div class="bold">BASILARE:</div> NIHSS ‚â•10, finestra 24h
                    </div>
                    <div class="criteria-box">
                        <div class="bold">FINESTRA ESTESA (6-24h):</div><br>
                        <div class="bold">DAWN:</div> &lt;80aa: NIHSS‚â•10+core&lt;31ml<br>
                        &lt;80aa: NIHSS‚â•20+core 31-59ml<br>
                        &gt;80aa: NIHSS‚â•10+core&lt;21ml<br>
                        <div class="bold">DEFUSE-3:</div> 6-16h, core&lt;70ml, mismatch‚â•15ml, ratio‚â•1,8
                    </div>
                </div>
            </div>

            <!-- COMPLICANZE TROMBOLISI -->
            <div class="section">
                <div class="section-title urgent">‚ö†Ô∏è COMPLICANZE TROMBOLISI</div>
                <div class="section-content">
                    <div class="text-content">
                        <div class="bold">Emorragiche (6-7%):</div>
                        <ul>
                            <li>ICH sintomatica: stop IVT + TC</li>
                            <li>Se NIHSS +4: stop IVT + imaging</li>
                            <li>Emorragie extracraniche maggiori</li>
                        </ul>
                        <div class="bold">Altre:</div>
                        <ul>
                            <li>Angioedema orolinguale (ACE-i)</li>
                            <li>Reazioni allergiche</li>
                            <li>Riocclusione (18%)</li>
                        </ul>
                        <div class="bold">Gestione ICH:</div> PCC-4F, neurochirurgia
                    </div>
                </div>
            </div>

            <!-- MONITORAGGIO POST-IVT -->
            <div class="section">
                <div class="section-title">üìä MONITORAGGIO POST-IVT</div>
                <div class="section-content">
                    <div class="text-content">
                        <div class="bold">PA:</div> &lt;180/105 x 24h (ogni 15min x 2h)<br>
                        <div class="bold">NIHSS:</div> ogni 15min x 1h, poi 30min x 5h<br>
                        <div class="bold">Lab:</div> emocromo + coag a 6-24h<br>
                        <div class="bold">TC controllo:</div> 22-36h<br>
                        <div class="bold">ASA:</div> dopo 24h + TC negativa
                    </div>
                </div>
            </div>
        </div>

        <!-- TAB 2: FARMACI E DETTAGLI -->
        <div class="tab-content" id="tab1">
            <!-- DOSAGGI -->
            <div class="section">
                <div class="section-title success">üíä DOSAGGI FARMACI</div>
                <div class="section-content">
                    <div class="dosage">
                        <div class="bold">TENECTEPLASE (preferita):</div>
                        0,25 mg/kg bolo (max 25mg)
                    </div>
                    
                    <table>
                        <tr><th>Peso</th><th>Tenecteplase</th></tr>
                        <tr><td>&lt;60 kg</td><td>3ml (15mg)</td></tr>
                        <tr><td>60-69 kg</td><td>3,5ml (17,5mg)</td></tr>
                        <tr><td>70-79 kg</td><td>4ml (20mg)</td></tr>
                        <tr><td>80-89 kg</td><td>4,5ml (22,5mg)</td></tr>
                        <tr><td>‚â•90 kg</td><td>5ml (25mg)</td></tr>
                    </table>
                    
                    <div class="dosage">
                        <div class="bold">ALTEPLASE:</div>
                        0,9 mg/kg (max 90mg)<br>
                        10% bolo 2min + 90% in 60min
                    </div>
                </div>
            </div>

            <!-- CONTROINDICAZIONI -->
            <div class="section">
                <div class="section-title urgent">‚ö†Ô∏è CONTROINDICAZIONI</div>
                <div class="section-content">
                    <div class="two-column">
                        <div>
                            <div class="bold">Cerebrali/Strutturali:</div>
                            <ul>
                                <li class="contraindication">ICH/ESA (anche sospetta)</li>
                                <li class="contraindication">Neoplasia intra-assiale</li>
                                <li class="contraindication">MAV/aneurisma non trattati</li>
                            </ul>
                            <div class="bold">Eventi recenti:</div>
                            <ul>
                                <li class="contraindication">Stroke/trauma/chir. intracr. &lt;3m (valutare caso per caso)</li>
                                <li class="contraindication">Chirurgia maggiore &lt;14gg</li>
                            </ul>
                        </div>
                        <div>
                            <div class="bold">Coagulopatie:</div>
                            <ul>
                                <li class="contraindication">INR &gt;1,7, PLT &lt;100k</li>
                                <li class="contraindication">DOAC &lt;48h, eparina+aPTT‚Üë</li>
                                <li class="contraindication">Endocardite, diss. aortica</li>
                            </ul>
                            <div class="bold">Metaboliche/Altre:</div>
                            <ul>
                                <li class="contraindication">Glicemia &lt;50 o &gt;400</li>
                                <li class="contraindication">PA &gt;185/110 refrattaria</li>
                                <li class="contraindication">STEMI &lt;7 giorni</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- ANTICOAGULANTI -->
            <div class="section">
                <div class="section-title warning">ü©∏ ANTICOAGULANTI E IVT</div>
                <div class="section-content">
                    <div class="highlight-note">
                        NB: EVT NON controindicata in anticoagulati/trombocitopenici
                    </div>
                    
                    <table>
                        <tr><th>Farmaco</th><th>IVT OK se:</th></tr>
                        <tr><td><div class="bold">Warfarin</div></td><td>INR ‚â§1,7<br>Se &gt;1,7: casi selezionati dopo PCC-4F</td></tr>
                        <tr><td><div class="bold">Dabigatran</div></td><td>aPTT norm + TT &lt;60s<br>o Hemoclot &lt;50ng/ml (6h)<br>o Idarucizumab 2√ó2,5g</td></tr>
                        <tr><td><div class="bold">LMWH</div></td><td>Dose prof: sempre OK<br>Dose terap &lt;48h: aPTT &lt;40s e iXa &lt;0,1</td></tr>
                        <tr><td><div class="bold">Xaban</div></td><td>&gt;24h con buona funz renale<br>o &lt;24h: iXa &lt;20ng/ml + antiXa &lt;0,5 + PT &lt;1,4</td></tr>
                    </table>
                    
                    <div class="text-content" style="color: #d32f2f; font-weight: bold;">
                        ‚Ä¢ NO Andexanet per IVT ‚Ä¢ Preferire EVT diretta se dubbi
                    </div>
                </div>
            </div>

            <!-- IPERGLICEMIA -->
            <div class="section">
                <div class="section-title warning">üçØ IPERGLICEMIA &gt;400mg/dL</div>
                <div class="section-content">
                    <div class="two-column">
                        <div>
                            <div class="bold">1.</div> Conferma con prelievo venoso<br>
                            <div class="bold">2.</div> Se confermata:<br>
                            &nbsp;&nbsp;&nbsp;<span class="bold">Insulina regolare:</span> 4-6UI EV<br>
                            &nbsp;&nbsp;&nbsp;(0,04-0,06ml Actrapid 100UI/ml)<br>
                            &nbsp;&nbsp;&nbsp;Iniezione EV lenta (1-2min)
                        </div>
                        <div>
                            <div class="bold">3.</div> Ricontrollo ogni 15-30min<br>
                            <div class="bold">4.</div> Rivaluta IVT se glicemia &lt;350<br>
                            &nbsp;&nbsp;&nbsp;e nessun stroke mimic
                        </div>
                    </div>
                </div>
            </div>

            <!-- EMERGENZE -->
            <div class="section">
                <div class="section-title urgent">üöë GESTIONE EMERGENZE</div>
                <div class="section-content">
                    <div class="emergency-grid">
                        <div>
                            <div class="emergency-item">
                                <div class="bold">Angioedema orolinguale:</div>
                                ‚Ä¢ Stop Alteplase + ACE-i<br>
                                ‚Ä¢ <span class="bold">Metilprednisolone</span> 125mg EV<br>
                                ‚Ä¢ <span class="bold">Clorfeniramina</span> 10mg EV<br>
                                ‚Ä¢ Se grave: <span class="bold">Adrenalina</span> 0,3ml SC<br>
                                ‚Ä¢ Alt: <span class="bold">Icatibant</span> 3ml (30mg) SC
                            </div>
                            
                            <div class="emergency-item">
                                <div class="bold">Sindrome riperfusione:</div>
                                ‚Ä¢ Cefalea, crisi, alteraz. coscienza<br>
                                ‚Ä¢ PA target &lt;120/80 (labetalolo)
                            </div>
                        </div>
                        
                        <div>
                            <div class="emergency-item">
                                <div class="bold">Ipotensione:</div>
                                ‚Ä¢ Liquidi EV + vasopressori<br>
                                ‚Ä¢ Se bradicardia: Atropina 0,5mg IV
                            </div>
                            
                            <div class="emergency-item">
                                <div class="bold">ICH sintomatica:</div>
                                ‚Ä¢ Stop IVT immediato<br>
                                ‚Ä¢ PCC-4F 25-50 UI/kg<br>
                                ‚Ä¢ Acido tranexamico 1g EV<br>
                                ‚Ä¢ Neurochirurgia urgente
                            </div>
                            
                            <div class="emergency-item">
                                <div class="bold">Se NIHSS +4:</div> Stop IVT + TC urgente
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        function showTab(index) {
            // Hide all tab contents
            const contents = document.querySelectorAll('.tab-content');
            contents.forEach(content => content.classList.remove('active'));
            
            // Remove active class from all tabs
            const tabs = document.querySelectorAll('.tab');
            tabs.forEach(tab => tab.classList.remove('active'));
            
            // Show selected tab content and mark tab as active
            document.getElementById(`tab${index}`).classList.add('active');
            document.querySelectorAll('.tab')[index].classList.add('active');
        }
    </script>
</body>
</html>
